Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Ra Pharmaceuticals, Inc. (RARX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/06/2020 SC 13D/A NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Ra Pharmaceuticals, Inc.
10/17/2019 SC 13D/A NEW ENTERPRISE ASSOCIATES 13 LP reports a 13% stake in Ra Pharmaceuticals, Inc.
10/11/2019 SC 13D/A RA CAPITAL MANAGEMENT, LLC reports a 10.3% stake in Ra Pharmaceuticals, Inc.
03/08/2019 SC 13D/A MORGENTHALER VENTURE PARTNERS IX LP reports a 4.7% stake in Ra Pharmaceuticals, Inc.
01/22/2019 SC 13D/A MORGENTHALER VENTURE PARTNERS IX LP reports a 6.1% stake in Ra Pharmaceuticals, Inc.
01/07/2019 SC 13D/A MORGENTHALER VENTURE PARTNERS IX LP reports a 7.1% stake in Ra Pharmaceuticals, Inc.
03/02/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/27/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/26/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/16/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/23/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy